> Details

Berry, James D.; Cudkowicz, Merit E.; Windebank, Anthony J.; Staff, Nathan P.; Owegi, Margaret; Nicholson, Katherine; McKenna-Yasek, Diane; Levy, Yossef S.; Abramov, Natalie; Kaspi, Haggai; Mehra, Munish; Aricha, Revital; Gothelf, Yael; Brown, Robert H.

NurOwn, phase 2, randomized, clinical trial in patients with ALS : Safety, clinical, and biomarker results

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: NurOwn, phase 2, randomized, clinical trial in patients with ALS : Safety, clinical, and biomarker results : Safety, clinical, and biomarker results
  • Contributor: Berry, James D.; Cudkowicz, Merit E.; Windebank, Anthony J.; Staff, Nathan P.; Owegi, Margaret; Nicholson, Katherine; McKenna-Yasek, Diane; Levy, Yossef S.; Abramov, Natalie; Kaspi, Haggai; Mehra, Munish; Aricha, Revital; Gothelf, Yael; Brown, Robert H.
  • Published: Ovid Technologies (Wolters Kluwer Health), 2019
  • Published in: Neurology, 93 (2019) 24
  • Language: English
  • DOI: 10.1212/wnl.0000000000008620
  • ISSN: 0028-3878; 1526-632X
  • Origination:
  • Footnote: